Assessment of GABA-B metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking

被引:51
作者
Tanchuck, Michelle A. [1 ]
Yoneyama, Naomi [1 ]
Ford, Matthew M. [1 ]
Fretwell, Andrea M. [2 ]
Finn, Deborah A. [1 ,2 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA
[2] Portland Alcohol Res Ctr, Dept Vet Affairs Med Res, Portland, OR 97239 USA
关键词
Mice; Alcohol; Operant; Naltrexone; Baclofen; MPEP; CUE-INDUCED REINSTATEMENT; ALCOHOL-SEEKING BEHAVIOR; IN-THE-DARK; ETHANOL-CONSUMPTION; AGONIST BACLOFEN; C57BL/6; MICE; PREFERRING P; DOUBLE-BLIND; NALTREXONE; ANTAGONIST;
D O I
10.1016/j.alcohol.2010.07.009
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
Drinking to intoxication or binge drinking is a hallmark characteristic of alcohol abuse. Although hard to model in rodents, the scheduled high alcohol consumption (SHAC) procedure generates high, stable ethanol intake and blood ethanol concentrations in mice to levels consistent with definitions of binge drinking. The purpose of the present studies was to determine the effects of pharmacological manipulation of the opioidergic, glutamatergic, and gamma-aminobutyric acid (GABA)ergic systems on binge drinking with the SHAC procedure. Parallel manipulations were conducted in mice trained in operant self-administration of either sucrose or ethanol. For the SHAC procedure, genetically heterogeneous Withdrawal Seizure Control mice were given varying periods of fluid access, with a 30-min ethanol session every third day (total of seven). Mice were pretreated intraperitoneally with naltrexone (0, 0.6, or 1.25 mg/kg), baclofen (0, 2.5, or 5.0 mg/kg), or 2-methyl-6-(phenylethyny1)-pyridine (MPEP; 0, 3.0, or 10.0 mg/kg) before each ethanol session. For the operant self-administration procedure, separate groups of C57BL16 mice were trained to complete a single response requirement (16 presses on the active lever) to gain 30 min of access to an ethanol or a sucrose solution. Mice received pretreatments of the same doses of naltrexone, MPEP, or baclofen before the self-administration sessions, with saline injections on intervening days. Naltrexone produced a dose-dependent decrease in binge drinking, and the highest dose also significantly decreased operant self-administration of ethanol and sucrose. Both doses of baclofen significantly decreased binge alcohol consumption, but the higher dose also tended to decrease water intake. The highest dose of baclofen also significantly decreased operant self-administration of sucrose. MPEP (10 mg/kg) significantly decreased binge alcohol consumption and sucrose self-administration. These results indicate that manipulation of the opioidergic, glutamatergic, and GABAergic systems significantly decreased binge drinking. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 44
页数:12
相关论文
共 89 条
[1]
Addolorato G, 2000, ALCOHOL CLIN EXP RES, V24, P67, DOI 10.1097/00000374-200001000-00011
[2]
Baclofen efficacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study [J].
Addolorato, G ;
Caputo, F ;
Capristo, E ;
Domenicali, M ;
Bernardi, M ;
Janiri, L ;
Agabio, R ;
Colombo, G ;
Gessa, GL ;
Gasbarrini, G .
ALCOHOL AND ALCOHOLISM, 2002, 37 (05) :504-508
[3]
Role of the GABAB receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives [J].
Addolorato, Giovanni ;
Leggio, Lorenzo ;
Cardone, Silvia ;
Ferrulli, Anna ;
Gasbarrini, Giovanni .
ALCOHOL, 2009, 43 (07) :559-563
[4]
[3H]methoxymethyl-3-[(2-methylyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain:: In vitro and in vivo characterization [J].
Anderson, JJ ;
Rao, SP ;
Rowe, B ;
Giracello, DR ;
Holtz, G ;
Chapman, DF ;
Tehrani, L ;
Bradbury, MJ ;
Cosford, NDP ;
Varney, MA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :1044-1051
[5]
Effect of baclofen on alcohol and sucrose self-administration in rats [J].
Anstrom, KK ;
Cromwell, HC ;
Markowski, T ;
Woodward, DJ .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2003, 27 (06) :900-908
[6]
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking [J].
Anton, RF ;
Drobes, DJ ;
Voronin, K ;
Durazo-Avizu, R ;
Moak, D .
PSYCHOPHARMACOLOGY, 2004, 173 (1-2) :32-40
[7]
Current pharmacotherapies of alcoholism: A U. S. perspective [J].
Anton, RF ;
Swift, RM .
AMERICAN JOURNAL ON ADDICTIONS, 2003, 12 :S53-S68
[8]
mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior [J].
Bäckström, P ;
Bachteler, D ;
Koch, S ;
Hyytiä, P ;
Spanagel, R .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) :921-928
[9]
Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism [J].
Bechtholt, AJ ;
Cunningham, CL .
BEHAVIORAL NEUROSCIENCE, 2005, 119 (01) :213-223
[10]
GABAB receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6j mice [J].
Besheer J. ;
Lepoutre V. ;
Hodge C.W. .
Psychopharmacology, 2004, 174 (3) :358-366